NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	preexposure prophylaxis against rabies
Date of first enrollment	18/11/2013
Target sample size	30
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : KD-357 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Intramuscular administration of 1.0 mL/dose on Days 0, 7, and 28. (This is the standard pre-exposure schedule)

Outcome(s)

Primary Outcome	Rabies virus neutralizing antibody seropositive rate
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	<= 19age old
Gender	Both
Include criteria	(1) Subjects who are healthy Japanese under 20 at the time of obtaining informed consent (2) Legally acceptable representatives who are able to give written informed consent.
Exclude criteria